| |
著者: Kelli Kelderhouse, Julie Smith Taylor
雑誌名: Nurs Womens Health. 2013 Aug-Sep;17(4):294-305. doi: 10.1111/1751-486X.12048.
Abstract/Text
Premenstrual dysphoric disorder (PMDD) affects 5 to 8 percent of women and can significantly decrease their quality of life. Symptoms generally present during the late luteal phase of the menstrual cycle and can affect women emotionally, behaviorally, cognitively and physiologically. This article reviews the clinical literature on PMDD and the evidence behind various methods of symptom management. Evidence suggests that a holistic approach, including lifestyle modifications, pharmacotherapy and cognitive behavioral therapy, is most beneficial for symptom reduction and improvement in daily functioning and quality of life.
© 2013 AWHONN.
PMID 23957795 Nurs Womens Health. 2013 Aug-Sep;17(4):294-305. doi: 10.1111/1751-486X.12048.
|
